Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
FWBI | Entero Therapeutics, Inc. | Chairman and CEO, Director | $38.3 K | -$13 K | -25.3% | Jul 2, 2024 |
BWV | Onconetix, Inc. | Director | May 31, 2023 | |||
RENB | RENOVARO INC. | Director | Jun 25, 2024 | |||
ZVSA | ZyVersa Therapeutics, Inc. | Director | Jan 5, 2023 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|